Pitavastatin (59 mg/kg; p.o.; twice daily for 28 days) causes significant tumour regression. Pitavastatin (0.1 mg/kg; p.o; daily for 12 weeks) retards the progression of atherosclerosis formation and improves NO bioavailability by eNOS up-regulation and decrease of O2- in diet induced severe hyperlipidemia rabbit model.